MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
ImmuCell Corporation Depreciation & Amortization 2011-2026 | ICCC
Annual Depreciation & Amortization ImmuCell Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.78 M | 2.73 M | 2.7 M | 2.47 M | 2.44 M | 2.33 M | 2.25 M | 1.5 M | 885 K | 783 K | 526 K | 446 K | 414 K | 400 K | 413 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.78 M | 400 K | 1.54 M |
Quarterly Depreciation & Amortization ImmuCell Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 709 K | 663 K | 671 K | - | 686 K | 666 K | 662 K | - | 696 K | 680 K | 652 K | - | 628 K | 625 K | 617 K | - | 613 K | 618 K | 615 K | - | 596 K | 568 K | 555 K | - | 563 K | 565 K | 564 K | - | 378 K | 281 K | 280 K | - | 627 K | 421 K | 213 K | - | 569 K | 368 K | 163 K | - | 378 K | 244 K | 116 K | - | 331 K | 227 K | 112 K | - | 293 K | 196 K | 97.1 K | - | 305 K | 210 K | 103 K | - | 307 K | 211 K | 105 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 709 K | 97.1 K | 439 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M |  China |
 |
Athira Pharma
ATHA
|
972 K | - | - | $ 269 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
546 K | $ 0.77 | -4.12 % | $ 35.2 M |  Israel |
 |
Exelixis
EXEL
|
29.1 M | $ 48.16 | 4.22 % | $ 13.1 B | USA |
 |
Fortress Biotech
FBIO
|
403 K | $ 2.39 | -0.42 % | $ 66.7 M | USA |
|
Forte Biosciences
FBRX
|
64 K | $ 24.02 | -8.22 % | $ 311 M | USA |
 |
Compugen Ltd.
CGEN
|
461 K | $ 2.9 | 1.4 % | $ 271 M | Israel |
 |
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
920 K | $ 22.4 | -0.71 % | $ 3.71 B | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
105 K | $ 3.14 | - | $ 653 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 3.51 | -0.85 % | $ 5.78 M | Israel |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M |  Canada |
 |
Gilead Sciences
GILD
|
370 M | $ 131.33 | -2.04 % | $ 163 B | USA |
 |
Genprex
GNPX
|
6.69 K | $ 0.87 | 0.58 % | $ 811 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
700 K | $ 21.17 | 2.47 % | $ 2.69 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
1 K | - | 10.36 % | $ 9.8 M | USA |
 |
Aravive
ARAV
|
886 K | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
487 K | - | 17.91 % | $ 11.1 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
19.5 M | $ 54.83 | 4.6 % | $ 4.93 B |  Schweiz |
 |
Autolus Therapeutics plc
AUTL
|
8.3 M | $ 1.57 | -2.48 % | $ 418 M |  Britain |